Protective effects of Allium sativum against defects of hypercholesterolemia on pregnant rats and their offspring

International Journal of Clinical and Experimental Medicine

Volumn 3, Issue 2, 2010, Pages 152-163

  El Sayyad, Hassan I ^a   Abou El Naga, Amoura M ^a   Gadallah, Abdelalim A ^a   Bakr, Iman H ^a  

^a Mansoura University   (Egypt)

Author keywords

Allium sativum; Cardiovascular; Hypercholersterolemia; Offspring; Pregnant rats

Indexed keywords

CHOLESTEROL; CREATINE KINASE; GARLIC EXTRACT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABORTION; ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; ATHEROSCLEROSIS; BIRTH; BLOOD VESSEL; BODY WEIGHT DISORDER; BONE DISEASE; CELL INFILTRATION; CELL SWELLING; CHOLESTEROL BLOOD LEVEL; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EFFICACY; EDEMA; ENZYME ACTIVITY; EOSINOPHILIA; FEMALE; GESTATIONAL AGE; HEART MITOCHONDRION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HYPERCHOLESTEROLEMIA; INCIDENCE; INFLAMMATORY CELL; LEUKOCYTE; LIPOPROTEIN BLOOD LEVEL; MATERNAL DISEASE; MORPHOMETRICS; NECROSIS; NEWBORN; NONHUMAN; PREGNANCY; PROGENY; RAT; SKELETON; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ALLIUM SATIVUM; RATTUS;

EID: 77955529319     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Goldstein JL, Hobbs HH, Brown MS. Familial Hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001;2863-2913.
2. Vattikuti R. and Towler, DA. osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004;286 (5):E686-96.
3. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM. The pathogenesis of atherosclerosis: an overview. Clin Cardiol 1991;14(1):1-16.
4. Blania G. and Spangenberg B. Formation of allicin from dried garlic (Allium sativum): a simple HPTLC ethod for simultaneous determination of allicin and ajoene in dried garlic and garlic preparations. Planta Med 1991;57(4):371-375.
5. Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health-care professionals. London:Pharmaceutical Press, 1996; ix, 296.
6. Bordia AK, Joshi HK, Sanadhya YK, Bhu N. Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease. Atherosclerosis 1977;28 (2): 155-159.
7. Bordia A, Sanadhya SK, Rathore AS and Bitu N. Essential oil of garlic on blood lipids and fibrinolytic activity in patients of coronary artery disease (Part 1). J Assoc Phys Ind 1978;26:327-331.
8. Harenberg J, Giese C and Zimmermann R. Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoprotienemia. Atherosclerosis 1988;74(3): 247-249.
9. Lau B, Lam F, Wang CR. Effect of an odourmodified garlic preparation on blood lipids. Nutr Res 1987;7:139-149.
10. Phelps S and Harris W. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 1993;28(5): 475-477.
11. Koscielny J, Klubendorf D, Latza R, Schmitt R, Radtke H, Siegel G. and Kiesewetter H. The antiatherosclerotic effect of Allium sativum. Atherosclerosis. 1999;144(1):237-249.
12. Lata S, Saxena KK, Bhasin V, Saxena RS, Kumar A and Srivastava VK. Beneficial effects of Allium sativum, Allium cepa and Commiphora mukul on experimental hyperlipidemia and atherosclerosis --a comparative evaluation. J Postgrad Med 1991;37 (3):132-135.
13. Choudhary, R. (2008). Benificial effect off Allium sativum and Allium tuberosum on experimental hyperlipidemia and atherosclerosis. Pak J Physiol;4(2):1-3.
14. Silagy C, Neil A. Garlic as a lipid lowering agenta meta-analysis. J R Coll Physicians Lond 1994;28(1):39-45.
15. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol: a metaanalysis. Ann Intern Med 1993;119(7 Pt 1):599-605
16. Deeg R and Ziegenhorn J. Kinetic enzymic method for automated determination of total cholesterol in serum. Clin Chem 1983;29(10): 1798-1802.
17. Fossati P and Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that proceduces hydrogen peroxide. Clin Chem 1982;28(10).2077-2080.
18. Grove TH. Effect of reagent PH on determination of the high-density lipoprotein cholesterol by precipitation with sodium phototungestatemagnesium. Clin Chem 1979;25 (4): 560-564.
19. Friedewald WT, Levy RI and Fredrickson DS. Estimation of low density lipoprotein cholesterol in plasma without use preparative ultracentrifuge. Clin Chem 1972;18 (6): 499-502.
20. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol. 2004;160 (5):421-429.
21. Rózycka Z, Lewicki Z and Wutzen J. Dynamics of lesions to the myocardium in experimental hyper cholesterolemia. Pol Tyg Lek. 1989;44(10-11):247-52.
22. Caligiuri G, Levy B, Pernow J, Thorén P, Hansson GK. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci USA 1999;96(12):6920-6924.
23. Zhang S, Picard MH, Vasile E, Zhu Y, Raffai RL, Weisgraber KH and Krieger M. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type Ideficient, hypomorphic apolipoprotein ER61 mice. Circulation 2005; 111(25):3457-3464.
24. Oliveira HC, Cosso RG, Alberici LC, Maciel EN, Salerno AG, Dorighello GG, Velho JA, de Faria EC, Vercesi AE. Oxidative stress in atherosclerosisprone mouse is due to low antioxidant capacity of mitochondria. FASEB J 2005;19(2):278-280.
25. Vercesi AE, Kowaltowski AJ, Oliveira HCF, Castilho RF. Mitochondrial Ca2+ transport, permeability transition and oxidative stress in cell death: implications in cardiotoxicity, neurodegeneration and dyslipidemias. Front Biosci 2006;11: 2554-2564.
26. Wang TD, Chen WJ, Su SS, Lo SC, Lin WW, Lee YT. Increased cardiomyocyte apoptosis following ischemia and reperfusion in diet-induced hypercholesterolemia: relation to Bcl-2 and Bax proteins and caspase-3 activity. Lipids 2002;37 (4):385-94.
27. Fontes CJ, Ameido L, Paiva I, Tavare P, Cabrita S, Wulfroth P, Matos BM and Teixeira F. Influence of 0.1 or o.2% cholesterol enriched diets on the induction of atherosclerosis and aorta reactivity in vitro. J. Cardiovasc. Pharmacol 1998;31:690-699.
28. Ismail MF, Gad MZ, Hamdy MA. Study of the hypolipidemic properties of pectin, garlic and ginseng in hypercholesterolemic rabbits. Pharmacol Res 1999;39(2):157-66.
29. McConnell MV, Aikawa M, Maier SE, Ganz P, Libby P, Lee RT. MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol 1999;19:1956-1959.
30. Sun YP, Lu NC, Parmley WW and Hollenbeck CB. Effects of cholesterol diets on vascular function and atherogenesis in rabbits. Proc Soc Exp Biol Med 2000;224:166-171.
31. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Arch. A Pathol Anat Histopathol 1992;421:277-290.
32. Alkemade FE, Gittenberger-de Groot AC, Schiel AE, VanMunstern JD, Hogers B, Van Vliet LS, Poelmann RE, Havekes LM, Willems van Dijk K, DeRuiter MC. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. Arterioscler Thromb Vasc Biol 2007;27(10):2228-2235.
33. Yeh YY and Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr 2001;131: 989S-993S.
34. Rahman K and Lowe GM. Garlic and Cardiovascular Disease: A Critical Review. J Nutr 2006;136(3): 736S-740S.
35. Dillon SA, Burmi RS, Lowe GM, Billington D, Rahman K. Antioxidant properties of aged garlic extract: an in vitro study incorporating human low density protein. Life Sci 2003;72:1583-94.
36. Dillon SA. Aged garlic extract as an antioxidant in cardiovascular disease [doctoral thesis]. Liverpool John Moores University, Liverpool, UK, 2002. pp 32-35.
37. Mogren I, Hogberg U, Stegmayr B, Lindahl B, Stenlund H. Fetal exposure, heredity and risk indicators for cardiovascular disease in a Swedish welfare cohort. Int J Epidemiol 2001;30 (4):853-862.
38. Roux C, Wolf C, Mulliez N, Gaoua W, Cormier V, Chevy F and Citadelle D. Role of cholesterol in embryonic development. Am J Clin Nutr 2000;71 (suppl):1270S-1279S.
39. Miyake Y, Tajima S, Funahashi T, Yamamoto A. Analysis of a recycling-impaired mutant of low density lipoprotein receptor in familial hypercholesterolemia. J Biol Chem 1989;264(28):16584-90.
40. Bonet B, Hauge-Gillenwater H, Zhu XD, Knopp RH. LDL oxidation and human placental trophoblast and macrophage cytotoxicity. Proc Soc Exp Biol Med 1998;217:203-211.
41. Stefulj J, Panzenboeck U, Becker T, Hirschmugl B, Schweinzer C, Lang I, Marsche G, Sadjak A, Lang U, Desoye G and Wadsack C. Human Endothelial Cells of the Placental Barrier Efficiently Deliver Cholesterol to the Fetal Circulation via ABCA1 and ABCG1. Circ Res 2009;104;600-608.
42. Viccica G, Vignali E, Marcocci C. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation. J Endocrinol Invest 2007;30(6):8-12.
43. Kojuri J, Vosoughi AR, Akrami M. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis. 2007;6:1-5.
44. Butt MS, Sultan MT, Butt MS, Iqbal J. Garlic: nature's protection against physiological threats. Crit Rev Food Sci Nutr 2009;49(6):538-551.
45. Asdaq SM, Inamdar MN, Asad M. Effect of conventional antihypertensive drugs on hypolipidemic action of garlic in rats. Indian J Exp Biol 2009;47(3):176-181.